ArticleTherapeutic advances in medical oncology2022

FOLFIRI (folinic acid, fluorouracil, and irinotecan) increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial.

Xiaowei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.